Median Technologies (Microsoft Azure)

On June 22, 2016 Median Technologies and Microsoft announced global cooperation within which the companies were engaged in joint development of new methods of identification, diagnostics and monitoring of oncological diseases by means of analytics of Big Data.

Partnership assumes installation of the IBIOPSY system on a cloud platform of Microsoft Azure thanks to what the first will be able to process and analyze medical pictures, using biological status lights of an organism, for the purpose of diagnostics and control of cancer therapy in real time.

Microsoft was engaged in the analysis of Big Data for fight against cancer

Thanks to connection to a cloud of Microsoft the IBIOPSY system will be available to medical institutions and doctors in the USA, Europe, Asia and other regions, providing development of the individualized medicine (when treatment is appointed pointwise according to genes of the specific patient) at cancer therapy and growth of volume of content in the field of medical visualization.

Besides, Median Technologies and Microsoft will focus on development of new methods of predictive analytics on the basis of machine learning technologies and data encryption to expand possibilities of use of a cloud of Azure by the medical centers, said in a joint statement of the company.

The individualized medicine cardinally changes use of diagnostic and biological data for appointment and performing treatment, doing it more preventive, purposeful and effective. Extraction of biomarkers from medical images is the cornerstone of the individualized medicine. Big Data and analytics allow to process and analyze effectively visual biomarkers which are important for early detection of cancer and monitoring of new target methods of treatment of oncology. Our cooperation with Microsoft will allow us to enter these solutions to daily clinical practice, using the global scale of a cloud platform of Azure.[1] head of Median Technologies Fredrik Brag

Notes